A review of the metabolism and pharmacokinetics of paroxetine in man.
about
The effects of selective serotonin reuptake inhibitors and their metabolites on S-mephenytoin 4'-hydroxylase activity in human liver microsomesDefining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributesThe influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder.Systemic modulation of serotonergic synapses via reuptake blockade or 5HT1A receptor antagonism does not alter perithreshold taste sensitivity in rats.The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants.The role of 5-HT1A receptors in mediating acute negative effects of antidepressants: implications in pediatric depression.Paroxetine reduces crying in young women watching emotional moviesParoxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling.Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers.Interaction study of the combined use of paroxetine and fosamprenavir-ritonavir in healthy subjects.A physiologically based pharmacokinetic model to predict disposition of CYP2D6 and CYP1A2 metabolized drugs in pregnant women.Pharmacology of serotonin uptake inhibitors: focus on fluvoxamine.The paroxetine effect on exercise performance depends on the aerobic capacity of exercising individualsPossible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders.Paroxetine-induced increase in activity of locus coeruleus neurons in adolescent rats: implication of a countertherapeutic effect of an antidepressant.Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein.The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes.
P2860
Q28378938-420814CC-9519-47F0-B1C9-E80139623C63Q28728799-4B4F7BDD-CC13-4114-804A-5D85A8613BA2Q33654737-5AFE9B98-BDFC-4022-9165-81FFADAB6FA9Q34048296-9F54052A-6E0C-4BB1-B047-2C8E0B828830Q35236618-914613BB-4C15-424C-8A0F-3480DC01FAE3Q35753190-C1A8C594-CF88-42B3-9D63-E008F1FFD2CEQ35775586-DE96EA39-1F41-4887-AC3B-7073BD2E15BBQ35827538-B1F347AB-C95A-4C4D-8E0E-DE7B805B0914Q36055505-4BD07492-E25B-4749-A32C-B71129FF4F0BQ36295441-F0D762D7-F492-41A9-9A39-302BF9E9590BQ36717181-8577D4A1-8091-455A-9659-230D8AFFB137Q37423099-520B90F7-E8FD-47EF-9B19-A6986842074EQ37709258-1B33BA9E-FFB3-44DC-8824-AB66A3D8D481Q39313611-66273A5F-BB73-4A99-B518-378BC57476B6Q41204358-3CFBD5DB-4138-4B60-A20A-0F1491AA4F02Q41595625-599068FE-3189-402E-9537-BD87294F8702Q42085353-4C3E1EEF-B678-4912-A34D-6BE83804744B
P2860
A review of the metabolism and pharmacokinetics of paroxetine in man.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
A review of the metabolism and pharmacokinetics of paroxetine in man.
@en
type
label
A review of the metabolism and pharmacokinetics of paroxetine in man.
@en
prefLabel
A review of the metabolism and pharmacokinetics of paroxetine in man.
@en
P2093
P1476
A review of the metabolism and pharmacokinetics of paroxetine in man.
@en
P2093
Haddock RE
Langley PF
Zussman BD
P577
1989-01-01T00:00:00Z